000 01523 a2200421 4500
005 20250518065821.0
264 0 _c20210728
008 202107s 0 0 eng d
022 _a1473-5687
024 7 _a10.1097/MEG.0000000000001511
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLee, Pei-Chang
245 0 0 _aLow dose of propranolol treatment is associated with better survival in cirrhotic patients with hepatic encephalopathy.
_h[electronic resource]
260 _bEuropean journal of gastroenterology & hepatology
_c03 2020
300 _a365-372 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic beta-Antagonists
_xadverse effects
650 0 4 _aHepatic Encephalopathy
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xcomplications
650 0 4 _aProportional Hazards Models
650 0 4 _aPropranolol
_xadverse effects
650 0 4 _aTaiwan
_xepidemiology
700 1 _aChen, Yu-Ju
700 1 _aChou, Yueh-Ching
700 1 _aLee, Kuei-Chuan
700 1 _aChen, Ping-Hsien
700 1 _aKao, Wei-Yu
700 1 _aHuang, Yi-Hsiang
700 1 _aHuo, Teh-Ia
700 1 _aLin, Han-Chieh
700 1 _aHou, Ming-Chih
700 1 _aLee, Fa-Yauh
700 1 _aWu, Jaw-Ching
700 1 _aSu, Chien-Wei
773 0 _tEuropean journal of gastroenterology & hepatology
_gvol. 32
_gno. 3
_gp. 365-372
856 4 0 _uhttps://doi.org/10.1097/MEG.0000000000001511
_zAvailable from publisher's website
999 _c30274991
_d30274991